TIZIANA LIFE SCIENCES PLC has a total of 17 patent applications. It decreased the IP activity by 42.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are MACREGEN INC, INTRACT PHARMA LTD and TARVEDA THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Canada | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | China | 1 | |
#7 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Shailubhai Kunwar | 16 |
Publication | Filing date | Title |
---|---|---|
CA3112868A1 | Composition and methods of treating inflammatory and autoimmune diseases | |
EP3706869A1 | Formulations of milciclib and therapeutic combinations of the same for use in the treatment of cancer | |
US2018092857A1 | Dactinomycin compositions and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia | |
AU2017319318A1 | Anti-CD3 antibody formulations |